Loading clinical trials...
Loading clinical trials...
Obinutuzumab Containing Conditioning Regimen for CLL Patients and Patients With Richter's Transformation Requiring an Allogeneic Stem Cell Transplantation
Conditions
Interventions
Obinutuzumab
Locations
7
Germany
Universitätsklinikum Bonn
Bonn, Germany
Universitätsklinikum Köln
Cologne, Germany
Universitätsklinikum Essen
Essen, Germany
Universitätsklinikum Heidelberg
Heidelberg, Germany
Universitätsklinikum Leipzig
Leipzig, Germany
Universitätsklinikum Magdeburg
Magdeburg, Germany
Start Date
November 13, 2017
Primary Completion Date
May 16, 2019
Completion Date
June 6, 2019
Last Updated
January 5, 2022
NCT06846671
NCT07218341
NCT06548152
NCT07030400
NCT05006716
NCT07277231
Lead Sponsor
German CLL Study Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions